These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2746904)

  • 21. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
    Kamisawa T; Tu Y; Kuwata G; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Matsukawa M
    Hepatogastroenterology; 2006; 53(72):816-8. PubMed ID: 17153430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinico-roentgenological preoperative diagnosis of biliary cancer].
    Volkova LP; Dobychina LI
    Khirurgiia (Mosk); 1965 Apr; 41(4):90-5. PubMed ID: 5846209
    [No Abstract]   [Full Text] [Related]  

  • 23. [Radiological possibilities in the diagnosis of carcinoma of the gallbladder and bile ducts].
    Schulz HG
    Radiol Diagn (Berl); 1966; 7(1):73-80. PubMed ID: 5942892
    [No Abstract]   [Full Text] [Related]  

  • 24. Synchronous carcinoma of the gallbladder in a patient with intrahepatic bile duct carcinoma.
    Taniai N; Onda M; Tajiri T; Yoshida H; Naitou Z
    Hepatogastroenterology; 2000; 47(31):121-4. PubMed ID: 10690592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Carcinoma of the gallbladder and the common bile duct].
    Enderlin F
    Helv Chir Acta; 1974 Dec; 41(5-6):705-13. PubMed ID: 4615081
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical aspects, diagnosis and surgical treatment of a high blockage of the biliary tracts of tumors etiology].
    Zykov IuA; Seleznev GI; Nikitchenko SA; Emel'ianova ZI
    Khirurgiia (Mosk); 1980 Apr; (4):63-6. PubMed ID: 6154829
    [No Abstract]   [Full Text] [Related]  

  • 27. Double cancer of the gallbladder and common bile duct associated with anomalous junction of pancreaticobiliary ductal system.
    Ikoma A; Nakamura N; Miyazaki T; Maeda M
    Surgery; 1992 May; 111(5):595-600. PubMed ID: 1598682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
    Goodman MT; Yamamoto J
    Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of bile duct and gallbladder carcinoma by percutaneous transhepatic cholangioscopy].
    Nimura Y; Shionoya S
    Gan No Rinsho; 1986 Aug; 32(10):1246-8. PubMed ID: 3783953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract.
    Chow NH; Huang SM; Chan SH; Mo LR; Hwang MH; Su WC
    Anticancer Res; 1995; 15(3):1055-9. PubMed ID: 7645925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic ultrasound-guided FNA biopsy of bile duct and gallbladder: analysis of 53 cases.
    Meara RS; Jhala D; Eloubeidi MA; Eltoum I; Chhieng DC; Crowe DR; Varadarajulu S; Jhala N
    Cytopathology; 2006 Feb; 17(1):42-9. PubMed ID: 16417564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cancers of the bile ducts: diagnostic and therapeutic pitfalls].
    Moser G
    Rev Med Suisse Romande; 1985 Apr; 105(4):303-8. PubMed ID: 3892631
    [No Abstract]   [Full Text] [Related]  

  • 34. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoma of the gallbladder and bile ducts. A retrospective review.
    Dunbar LL; Adkins RB; Farringer J; Waterhouse G; O'Leary JP
    Am Surg; 1983 Feb; 49(2):94-104. PubMed ID: 6186171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant obstructive jaundice. Current status of surgical therapy].
    Schmidt HD; Rückert R; Brünner H
    Z Gastroenterol; 1977 Feb; 15(2):89-98. PubMed ID: 848073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neoplasms of the extrahepatic bile ducts. (Clinical contribution)].
    Segato G; Mantovani-Orsetti G; Candiani V; Pedrazzoli S
    Chir Patol Sper; 1969 Aug; 17(4):244-50. PubMed ID: 5398650
    [No Abstract]   [Full Text] [Related]  

  • 38. Early diagnosis of primary gallbladder carcinoma.
    Shi JS; Wang JS; Liu G; Yu YL; Lu Y; Jiao XY; Yang YJ; Li GC; Han Y
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):273-5. PubMed ID: 14612283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant neoplasms of the bile ducts].
    de Almeida JL; Martinez CA; Bromberg SH; Goffi FS
    AMB Rev Assoc Med Bras; 1985; 31(1-2):28-32. PubMed ID: 3877325
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatoscanning in cancer of the gallbladder and bile ducts].
    Rubin MP; Vert'ianov VA
    Sov Med; 1972 Feb; 35(2):39-43. PubMed ID: 5039422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.